Literature DB >> 10933664

Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialie: a UK-based survey.

R J Boon, T H Bacon, H L Robey, T J Coleman, A Connolly, P Crosson, S L Sacks.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10933664     DOI： 10.1093/jac/46.2.324

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis.

Authors:  Teresa H Bacon; Ron J Boon; Margaret Schultz; Cheryl Hodges-Savola
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

Review 2.  Slipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug-resistance.

Authors:  Anthony Griffiths
Journal:  Drug Resist Updat       Date:  2011-09-22       Impact factor: 18.500

3.  2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.

Authors:  Mårten Strand; Koushikul Islam; Karin Edlund; Christopher T Oberg; Annika Allard; Tomas Bergström; Ya-Fang Mei; Mikael Elofsson; Göran Wadell
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

4.  Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.

Authors:  C Danve-Szatanek; M Aymard; D Thouvenot; F Morfin; G Agius; I Bertin; S Billaudel; B Chanzy; M Coste-Burel; L Finkielsztejn; H Fleury; T Hadou; C Henquell; H Lafeuille; M E Lafon; A Le Faou; M C Legrand; L Maille; C Mengelle; P Morand; F Morinet; E Nicand; S Omar; B Picard; B Pozzetto; J Puel; D Raoult; C Scieux; M Segondy; J M Seigneurin; R Teyssou; C Zandotti
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

Review 5.  Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy.

Authors:  Teresa H Bacon; Myron J Levin; Jeffry J Leary; Robert T Sarisky; David Sutton
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.